To find if these predicted methylation sites in the catalase promoter are methylated, genomic DNA from normal B-cells (n = 5) or CLL cells (n = 32) were bisulfite converted, PCR amplified and sequenced. The gene discussed is CAT; the disease is B-cell chronic lymphocytic leukemia.